Skip to content

CYPH

CYPHERPUNK TECHNOLOGIES INC.

NASDAQ · Healthcare · Biotechnology · US

$2.53
−1.56%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
7.33x
P/E 2026E
—
P/E 2027E
6.00x
P/E 2028E
2.83x
P/S forward
2.20x

Trailing multiples

Trailing twelve months

P/E TTM
4.29x
PEG TTM
—
Price / book
1.96x
Price / sales
—
Price / cash flow
-9.39x

Enterprise value

Enterprise value
$265.1M
EV / sales
—
EV / EBITDA
-6.02x
EV / EBIT
-14.91x
Market cap
$272.6M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026